0000000000523018

AUTHOR

T. Andersson

showing 2 related works from this author

A randomized, multicenter, open-label controlled phase 2 trial of Foxy-5 as neoadjuvant therapy in patients with WNT5A negative colon cancer

2019

Oncologymedicine.medical_specialtybusiness.industryColorectal cancermedicine.medical_treatmentHematologymedicine.diseaseWNT5AOncologyInternal medicineMedicineIn patientOpen labelbusinessNeoadjuvant therapyWnt 5a proteinAnnals of Oncology
researchProduct

JEM–X inflight performance

2003

We summarize the inflight performance of JEM-X, the X-ray monitor on the INTEGRAL mission during the initial ten months of operations. The JEM-X instruments have now been tuned to stable operational conditions. The performance is found to be close to the pre-launch expectations. The ground calibrations and the inflight calibration data permit to determine the instruments characteristics to fully support the scientific data analysis. Reglero Velasco, Victor, Victor.Reglero@uv.es ; Martinez Nuñez, Silvia, Silvia.Martinez@uv.es

PhysicsInstrumentation: detectors; X-rays: general;010308 nuclear & particles physicsDetectors ; X–rays ; JEM-XDetectorsAstronomy and AstrophysicsUNESCO::ASTRONOMÍA Y ASTROFÍSICA:ASTRONOMÍA Y ASTROFÍSICA::Cosmología y cosmogonia [UNESCO]01 natural sciencesSpace and Planetary ScienceJEM-X0103 physical sciencesCalibrationUNESCO::ASTRONOMÍA Y ASTROFÍSICA::Cosmología y cosmogonia010303 astronomy & astrophysics:ASTRONOMÍA Y ASTROFÍSICA [UNESCO]X–raysRemote sensingAstronomy & Astrophysics
researchProduct